Robert Munday  LinkedIn

Executive Vice President,
Aeseptic and Biologics(Bob)

As an Executive Vice President, Bob is responsible for the operations at our Lexington and Grangemouth facilities and future plans around mAb’s and other biologic products. Bob’s functional expertise has enabled Piramal to drive synergies in sterile manufacturing, and offer integrated solutions supporting sterile fill finish customers. His experience in biologics supports Piramal leveraging potential new business opportunities supporting integrated customer offerings.

During his career Bob has led multiple sites to improved operational capabilities through operational excellence implementations and significantly improved customer satisfaction. His strength in transformational change has enabled significant commercial growth at multiple facilities.

Prior to Piramal, Bob led AGC Biologics, formerly CMC Biologics, Bothell site and was responsible for all site activities. During his time at CMC Biologics, the Bothell site transformed from a clinical focus to commercial biologics manufacturer. Bob is also a registered PMP and has led capital projects around the globe for multiple organizations. Bob’s educational background is from the US Naval Nuclear Power division.

Leadership Team

Peter DeYoung    LinkedIn

CEO, Piramal Global Pharma, Piramal Pharma Ltd.

Stuart Needleman    LinkedIn

Chief Commercial Officer &
Chief Patient Centricity Officer

Herve Berdou    LinkedIn

Chief Operating Officer, Piramal Pharma Solutions

Paolo Fiorino    LinkedIn

Executive Vice President, N.A  
API and Formulations

Debashish Chakravorty    LinkedIn

Executive Vice President, India and UK Formulations

Surinder Gulati    LinkedIn

Executive Vice President, Manufacturing, India API

Rashida Najmi    LinkedIn

Chief Quality Officer, Piramal Pharma Limited

Sandeep Oke    LinkedIn

Sr. Vice President –
Supply Chain